Comparison of LDL-C Reduction Using Different Evolocumab Doses and Intervals
Journal of cardiovascular pharmacology and therapeutics（2018）
Key words
evolocumab,dyslipidemia,PCSK9 inhibition,LDL-C,dosing
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined